Proteomics profiling identify CAPS as a potential predictive marker of tamoxifen resistance in estrogen receptor positive breast cancer

Por Johansson, Henrik J, Sanchez, Betzabe C, Forshed, Jenny, Stål, Olle, Fohlin, Helena, Lewensohn, Rolf, Hall, Per, Bergh, Jonas, Lehtiö, Janne, Linderholm, Barbro K
Publicado no Clin Proteomics (2015)

Retinoic acid receptor alpha is associated with tamoxifen resistance in breast cancer

Por Johansson, Henrik J., Sanchez, Betzabe C., Mundt, Filip, Forshed, Jenny, Kovacs, Aniko, Panizza, Elena, Hultin-Rosenberg, Lina, Lundgren, Bo, Martens, Ulf, Máthé, Gyöngyvér, Yakhini, Zohar, Helou, Khalil, Krawiec, Kamilla, Kanter, Lena, Hjerpe, Anders, Stål, Olle, Linderholm, Barbro K., Lehtiö, Janne
Publicado em 2013

Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor–Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00

Por Colleoni, Marco, Gray, Kathryn P., Gelber, Shari, Láng, István, Thürlimann, Beat, Gianni, Lorenzo, Abdi, Ehtesham A., Gomez, Henry L., Linderholm, Barbro K., Puglisi, Fabio, Tondini, Carlo, Kralidis, Elena, Eniu, Alexandru, Cagossi, Katia, Rauch, Daniel, Chirgwin, Jacquie, Gelber, Richard D., Regan, Meredith M., Coates, Alan S., Price, Karen N., Viale, Giuseppe, Goldhirsch, Aron
Publicado no J Clin Oncol (2016)

Comparative Proteome Analysis Revealing an 11-Protein Signature for Aggressive Triple-Negative Breast Cancer

Por Liu, Ning Qing, Stingl, Christoph, Look, Maxime P., Smid, Marcel, Braakman, René B.H., De Marchi, Tommaso, Sieuwerts, Anieta M., Span, Paul N., Sweep, Fred C.G.J., Linderholm, Barbro K., Mangia, Anita, Paradiso, Angelo, Dirix, Luc Y., Van Laere, Steven J., Luider, Theo M., Martens, John W.M., Foekens, John A., Umar, Arzu
Publicado em 2014